Furthermore, it suggests that alterations of the cytokine balance (i.e., WT vs. TNF KO) may skew the cytokine milieu towards a pro- or anti-inflammatory phenotype that alters the time course of progression of the SIRS. The gene discussed is TNF; the disease is systemic inflammatory response syndrome.